DBS Evaluation of Fujirebio INNOTEST® HCV Ab IV

NCT04317729 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C Virus Infection

Interventions

DEVICE: Fujirebio INNOTEST® HCV Ab IV assay

Sponsor

Foundation for Innovative New Diagnostics, Switzerland